Inspire Medical Systems, Inc. Operating Expenses
Inspire Medical Systems, Inc. (INSP) reported Operating Expenses of $156.47 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2024-11-04
- Inspire Medical Systems, Inc. operating expenses for the quarter ending 2024-09-30 was $156.47M, a 9.89% increase year-over-year.
- Inspire Medical Systems, Inc. operating expenses for the quarter ending 2024-06-30 was $160.94M, a 12.20% increase year-over-year.
- Inspire Medical Systems, Inc. operating expenses for the quarter ending 2024-03-31 was $154.47M, a 21.15% increase year-over-year.
- Inspire Medical Systems, Inc. operating expenses for the quarter ending 2023-12-31 was $155.16M, a 33.66% increase year-over-year.
- Inspire Medical Systems, Inc. operating expenses for fiscal 2023 was $568.49M, a 46.02% increase from fiscal 2022.
- Inspire Medical Systems, Inc. operating expenses for fiscal 2022 was $389.33M, a 62.25% increase from fiscal 2021.
- Inspire Medical Systems, Inc. operating expenses for fiscal 2021 was $239.97M, a 55.86% increase from fiscal 2020.
- Inspire Medical Systems, Inc. operating expenses for fiscal 2020 was $153.97M, a 49.04% increase from fiscal 2019.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2024-09-30 | $156.47M 10-Q · filed 2024-11-04 | $317.42M derived: sum of 2 quarters · filed 2024-11-04 | $471.89M 10-Q · filed 2024-11-04 | $627.05M derived: sum of 4 quarters · filed 2024-11-04 |
| 2024-06-30 | $160.94M 10-Q · filed 2024-08-06 | $315.41M 10-Q · filed 2024-08-06 | $470.57M derived: sum of 3 quarters · filed 2024-08-06 | $612.96M derived: sum of 4 quarters · filed 2024-11-04 |
| 2024-03-31 | $154.47M 10-Q · filed 2024-05-07 | $309.63M derived: sum of 2 quarters · filed 2024-05-07 | $452.02M derived: sum of 3 quarters · filed 2024-11-04 | $595.46M derived: sum of 4 quarters · filed 2024-11-04 |
| 2023-12-31 | $155.16M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-09 | $297.55M derived: sum of 2 quarters · filed 2024-11-04 | $440.99M derived: sum of 3 quarters · filed 2024-11-04 | $568.49M 10-K · filed 2024-02-09 |
| 2023-09-30 | $142.39M 10-Q · filed 2024-11-04 | $285.83M derived: sum of 2 quarters · filed 2024-11-04 | $413.34M 10-Q · filed 2024-11-04 | $529.42M derived: sum of 4 quarters · filed 2024-11-04 |
| 2023-06-30 | $143.44M 10-Q · filed 2024-08-06 | $270.95M 10-Q · filed 2024-08-06 | $387.03M derived: sum of 3 quarters · filed 2024-08-06 | $493.63M derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | $127.51M 10-Q · filed 2024-05-07 | $243.59M derived: sum of 2 quarters · filed 2024-05-07 | $350.19M derived: sum of 3 quarters · filed 2024-05-07 | $441.41M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $116.08M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-09 | $222.68M derived: sum of 2 quarters · filed 2024-02-09 | $313.90M derived: sum of 3 quarters · filed 2024-02-09 | $389.33M 10-K · filed 2024-02-09 |
| 2022-09-30 | $106.60M 10-Q · filed 2023-11-07 | $197.82M derived: sum of 2 quarters · filed 2023-11-07 | $273.25M 10-Q · filed 2023-11-07 | $342.31M derived: sum of 4 quarters · filed 2024-02-09 |
| 2022-06-30 | $91.22M 10-Q · filed 2023-08-01 | $166.65M 10-Q · filed 2023-08-01 | $235.72M derived: sum of 3 quarters · filed 2024-02-09 | $298.57M derived: sum of 4 quarters · filed 2024-02-09 |
| 2022-03-31 | $75.43M 10-Q · filed 2023-05-02 | $144.50M derived: sum of 2 quarters · filed 2024-02-09 | $207.35M derived: sum of 3 quarters · filed 2024-02-09 | $265.34M derived: sum of 4 quarters · filed 2024-02-09 |
| 2021-12-31 | $69.06M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-09 | $131.92M derived: sum of 2 quarters · filed 2024-02-09 | $189.91M derived: sum of 3 quarters · filed 2024-02-09 | $239.97M 10-K · filed 2024-02-09 |
| 2021-09-30 | $62.86M 10-Q · filed 2022-11-01 | $120.84M derived: sum of 2 quarters · filed 2022-11-01 | $170.90M 10-Q · filed 2022-11-01 | $216.81M derived: sum of 4 quarters · filed 2023-02-10 |
| 2021-06-30 | $57.98M 10-Q · filed 2022-08-02 | $108.05M 10-Q · filed 2022-08-02 | $153.96M derived: sum of 3 quarters · filed 2023-02-10 | $194.48M derived: sum of 4 quarters · filed 2023-02-10 |
| 2021-03-31 | $50.06M 10-Q · filed 2022-05-03 | $95.97M derived: sum of 2 quarters · filed 2023-02-10 | $136.49M derived: sum of 3 quarters · filed 2023-02-10 | $169.54M derived: sum of 4 quarters · filed 2023-02-10 |
| 2020-12-31 | $45.91M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $86.43M derived: sum of 2 quarters · filed 2023-02-10 | $119.48M derived: sum of 3 quarters · filed 2023-02-10 | $153.97M 10-K · filed 2023-02-10 |
| 2020-09-30 | $40.52M 10-Q · filed 2021-11-02 | $73.57M derived: sum of 2 quarters · filed 2021-11-02 | $108.06M 10-Q · filed 2021-11-02 | $140.02M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-06-30 | $33.04M 10-Q · filed 2021-08-03 | $67.53M 10-Q · filed 2021-08-03 | $99.49M derived: sum of 3 quarters · filed 2022-02-15 | $125.55M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-03-31 | $34.49M 10-Q · filed 2021-05-04 | $66.45M derived: sum of 2 quarters · filed 2022-02-15 | $92.51M derived: sum of 3 quarters · filed 2022-02-15 | $115.62M derived: sum of 4 quarters · filed 2022-02-15 |
| 2019-12-31 | $31.96M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $58.02M derived: sum of 2 quarters · filed 2022-02-15 | $81.13M derived: sum of 3 quarters · filed 2022-02-15 | $103.30M 10-K · filed 2022-02-15 |
| 2019-09-30 | $26.06M 10-Q · filed 2020-11-02 | $49.17M derived: sum of 2 quarters · filed 2020-11-02 | $71.34M 10-Q · filed 2020-11-02 | $89.61M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $23.11M 10-Q · filed 2020-08-04 | $45.29M 10-Q · filed 2020-08-04 | $63.55M derived: sum of 3 quarters · filed 2021-02-24 | $78.79M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $22.17M 10-Q · filed 2020-05-05 | $40.44M derived: sum of 2 quarters · filed 2021-02-24 | $55.67M derived: sum of 3 quarters · filed 2021-02-24 | $70.14M derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | $18.26M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $33.50M derived: sum of 2 quarters · filed 2021-02-24 | $47.97M derived: sum of 3 quarters · filed 2021-02-24 | $60.91M 10-K · filed 2021-02-24 |
| 2018-09-30 | $15.24M 10-Q · filed 2019-11-05 | $29.71M derived: sum of 2 quarters · filed 2019-11-05 | $42.65M 10-Q · filed 2019-11-05 | $54.57M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $14.47M 10-Q · filed 2019-08-06 | $27.42M 10-Q · filed 2019-08-06 | $39.34M derived: sum of 3 quarters · filed 2020-02-25 | $48.69M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $12.94M 10-Q · filed 2019-05-07 | $24.86M derived: sum of 2 quarters · filed 2020-02-25 | $34.22M derived: sum of 3 quarters · filed 2020-02-25 | $43.27M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $11.92M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $21.28M derived: sum of 2 quarters · filed 2020-02-25 | $30.33M derived: sum of 3 quarters · filed 2020-02-25 | $38.55M 10-K · filed 2020-02-25 |
| 2017-09-30 | $9.36M 10-Q · filed 2018-11-06 | $18.41M derived: sum of 2 quarters · filed 2018-11-06 | $26.63M 10-Q · filed 2018-11-06 | |
| 2017-06-30 | $9.05M 10-Q · filed 2018-08-07 | $17.27M 10-Q · filed 2018-08-07 | ||
| 2017-03-31 | $8.22M 10-Q · filed 2018-06-07 | |||
| 2016-12-31 | $29.77M 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |